News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Ulrik Lassen, MD, PhD

Articles by Ulrik Lassen, MD, PhD

Diagnosis and Management of TRK Fusion Cancer

ByShivaani Kummar, MD, FACP,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Josh J. Carlson, PhD, MPH,Sean D. Sullivan, PhD, MSc, RPh,Ulrik Lassen, MD, PhD,Noah Federman, MD

January 11th 2022

Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer

ByJosh J. Carlson, PhD, MPH,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Noah Federman, MD,Ulrik Lassen, MD, PhD,Shivaani Kummar, MD, FACP,Sean D. Sullivan, PhD, MSc, RPh

January 11th 2022

Latest Updated Articles

Diagnosis and Management of TRK Fusion Cancer
January 11th 2022
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer
January 11th 2022

Trending on AJMC

Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute

Bringing CAR T-Cell Therapy Into Community Cancer Centers

The True Cost of Running a Community CAR T-Cell Program

Higher Weight-Adjusted Waist Index Tied to CKD Mortality, Study Finds

GLP-1 Prescribing in Young Children With Obesity Rises 310-Fold